Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News
    • DaVita explores sale...

    DaVita explores sale of physician network business - sources

    Written by Ruby Khatun Khatun Published On 2017-11-23T09:15:43+05:30  |  Updated On 18 Aug 2021 3:12 PM IST

    DaVita Inc, the largest U.S. provider of kidney care services, is exploring a sale of its physician network business, DaVita Medical Group, that could value the unit at up to $4 billion, according to people familiar with the matter.


    The deliberations are still in their preliminary stages, and DaVita may decide not to go through with a sale, the sources said on Wednesday, asking not to be identified because the matter is confidential.



    DaVita Medical Group could attract interest from a variety of bidders, including private equity firms and health insurers, the people said.

    DaVita did not immediately respond to a request for comment. The company is working with investment bank Goldman Sachs Group Inc on the potential sale, the sources added. Goldman declined to comment.



    DaVita Medical Group has been a significant drag on its parent company's performance in recent quarters. DaVita has attributed the decline to delayed payments from federal healthcare programme Medicare Advantage, and a recent uptick in the costs of treating some of their patients.

    "We recognize that the business is not achieving our capital return expectations nor is it contributing to [operating income] growth," Davita Chief Financial Officer Joel Ackerman said on an earnings call this month.


    In its most recent quarter, DaVita Medical Group reported an adjusted operating loss of $5 million.


    To boost profits and hold down costs, DaVita recently announced it was slashing 350 non-clinical positions at Davita Medical Group, which it said could produce annual savings of around $40 million in 2018.


    The company also said that it is "pursuing strategic alternatives for underperforming assets across our businesses and across markets."


    The outsourced physician services sector as a whole has been under pressure in recent months, with major players, including DaVita Medical Group, Mednax Inc and Envision Healthcare Corp, all struggling to adjust to changes in how healthcare providers are reimbursed.


    Federal reimbursement programs such as Medicare and Medicaid, for example, have been increasingly trying to shift to a so-called "value-based" payment model, where in some cases fixed payments are given to providers, who are then incentivized to control costs.


    Envision announced plans to explore strategic alternatives in November. It had earlier attracted investments from activist hedge funds Starboard Value and Corvex Management.


    Last week, Elliott Management, another activist hedge fund, announced a 7 percent stake in Mednax and said it should explore a potential sale. It joined activist Blue Harbor Group, which had previously bought into the stock.




    (Reporting by Carl O'Donnell in New York; Editing by Bill Rigby and Susan Thomas)



    businessDaVitaDaVita Medical GroupEnvision Healthcare CorpexploresGoldman Sachs Group Inchealth insurersHealthcareinvestment bankJoel Ackermankidney care servicesMednax IncnetworkphysicianSale
    Source : REUTERS

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Ruby Khatun Khatun
    Ruby Khatun Khatun
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok